This cohort study examines associations of the 9-valent human papillomavirus (HPV) vaccine with HPV-related cancers in males aged 9 to 26 years.
JAMA Oncology published a clinical update in Oncology on 09 Apr 2026.
The item focuses on Nine-Valent HPV Vaccination and Related Cancers.
Review the original article for the full source wording and details.